Galani, I.; Karaiskos, I.; Souli, M.; Papoutsaki, V.; Gkoufa, A.; Antoniadou, A.; Giamarellou, H.
Outbreak of High-Risk Clone ST323 Klebsiella pneumoniae Resistant to Ceftazidime–Avibactam Due to Acquisition of blaVEB-25 and to Cefiderocol Due to Mutated fiu Gene. Antibiotics 2025, 14, 223.
https://doi.org/10.3390/antibiotics14030223
AMA Style
Galani I, Karaiskos I, Souli M, Papoutsaki V, Gkoufa A, Antoniadou A, Giamarellou H.
Outbreak of High-Risk Clone ST323 Klebsiella pneumoniae Resistant to Ceftazidime–Avibactam Due to Acquisition of blaVEB-25 and to Cefiderocol Due to Mutated fiu Gene. Antibiotics. 2025; 14(3):223.
https://doi.org/10.3390/antibiotics14030223
Chicago/Turabian Style
Galani, Irene, Ilias Karaiskos, Maria Souli, Vassiliki Papoutsaki, Aikaterini Gkoufa, Anastasia Antoniadou, and Helen Giamarellou.
2025. "Outbreak of High-Risk Clone ST323 Klebsiella pneumoniae Resistant to Ceftazidime–Avibactam Due to Acquisition of blaVEB-25 and to Cefiderocol Due to Mutated fiu Gene" Antibiotics 14, no. 3: 223.
https://doi.org/10.3390/antibiotics14030223
APA Style
Galani, I., Karaiskos, I., Souli, M., Papoutsaki, V., Gkoufa, A., Antoniadou, A., & Giamarellou, H.
(2025). Outbreak of High-Risk Clone ST323 Klebsiella pneumoniae Resistant to Ceftazidime–Avibactam Due to Acquisition of blaVEB-25 and to Cefiderocol Due to Mutated fiu Gene. Antibiotics, 14(3), 223.
https://doi.org/10.3390/antibiotics14030223
